Affinity Asset Advisors’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.48M | Sell |
|
|||||
|
2025
Q1 | $10.4M | Buy |
|
|||||
|
2024
Q4 | $5.49M | Sell |
|
|||||
|
2024
Q3 | $7.64M | Buy |
|
|||||
|
2024
Q2 | $2.53M | Buy |
|
|||||
|
2024
Q1 | $1.55M | Sell |
|
|||||
|
2023
Q4 | $3.23M | Buy |
|
|||||
|
2023
Q3 | $791K | Sell |
|
|||||
|
2023
Q2 | $604K | Sell |
|
|||||
|
2023
Q1 | $5.31M | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $8.24M | Sell |
|
|||||
|
2021
Q3 | $30.7M | Buy |
|
|||||
|
2021
Q2 | $33.5M | Sell |
|
|||||
|
2021
Q1 | $35.6M | Buy |
|
|||||
|
2020
Q4 | $11M | Buy |
|